PTHS
AMEX · Biotechnology

Pelthos Therapeutics Inc

$22.99
-0.33 (-1.42%)
As of Feb 8, 2:15 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 12.22M 12.16M 13.52M
Net Income 1.67M 1.59M 1.78M
EPS
Profit Margin 13.7% 13.1% 13.2%
Rev Growth +12.4% +20.7% +15.7%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 35.24M 30.53M 34.79M
Total Equity 56.05M 48.64M 50.50M
D/E Ratio 0.63 0.63 0.69
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 2.79M 3.00M 3.51M
Free Cash Flow 1.30M 1.27M 1.44M